InvestorsHub Logo
Followers 1
Posts 31
Boards Moderated 0
Alias Born 08/23/2013

Re: Evaluate post# 30586

Wednesday, 03/11/2015 10:00:01 PM

Wednesday, March 11, 2015 10:00:01 PM

Post# of 703926
Actually Dr. Linda Liau, Dr. Robert Prins once published a paper in New England Journal of Medicine describing one patient in the previous P1 trial developed a robust CD8+ T-cell response to the pp65 immunodominant epitope of human cytomegalovirus (CMV).

www.nejm.org/doi/full/10.1056/NEJMc0804818

The problem with Duke's approach is patients must have CMV infected their tumors in the first place. So how many patients have that infection in place is a huge question.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News